Financially Speaking’s Thermo Fisher Scientific TMO Stock Holding History

Financially Speaking’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$32.4K	Sell	48 -42	-47%	-$25K	0.04%	49
2026 Q2	$44.2K	Hold	90	–	–	0.21%	31
2026 Q1	$44.2K	Sell	90 -10	-10%	-$5.43K	0.21%	31
2025 Q4	$57.9K	Hold	100	–	–	0.04%	52
2025 Q3	$48.5K	Hold	100	–	–	0.03%	64
2025 Q2	$40.5K	Buy	+100	New	+$41.8K	0.03%	58
2025 Q1	–	Sell	-100	Closed	-$52K	–	152
2024 Q4	$52K	Buy	+100	New	+$55K	0.04%	48

Other funds holding TMO

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Financially Speaking's TMO Position: Q3 2026 in Review

Financially Speaking reduced its Thermo Fisher Scientific (TMO) stake by 47% in Q3 2026, selling an estimated $25K and leaving 48 shares worth $32.4K. The position accounts for 0.04% of the portfolio, ranked #49.

Financially Speaking first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $57.9K in Q4 2025. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Financially Speaking held 48 shares of Thermo Fisher Scientific worth $32.4K as of Q3 2026.
Financially Speaking sold 42 Thermo Fisher Scientific shares in Q3 2026, an estimated $25K.
Thermo Fisher Scientific made up 0.04% of Financially Speaking's portfolio in Q3 2026, its #49 holding.
Financially Speaking first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
Financially Speaking's Thermo Fisher Scientific position peaked at $57.9K in Q4 2025.
1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Financially Speaking's 13F filing for Q3 2026, filed 4 Nov 2026.